Navigation Links
Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues
Date:5/12/2008

NEW YORK, May 12 /PRNewswire-USNewswire/ -- The Alliance for Lupus Research (ALR) commends the Senate on its passage of a resolution supporting the goals and ideals of National Women's Health Week that begins annually on Mother's Day. The resolution, introduced by Senators Russ Feingold (D-WI) and Olympia Snowe (R-ME) calls on all Americans to take the week of May 11th - May 17th as an opportunity to educate themselves on women's health issues, and recognizes the importance of Federally funded programs that provide research on common diseases in women, like lupus. ALR's main legislative priority is increased support for lupus research by Federal agencies such as the National Institute for Health, Health and Human Services, and Department of Defense Health Programs. The House version of the resolution introduced by Rep. Maurice Hinchey (NY-D) is expected to pass this week.

"Too many women - our nation's mothers, daughters, sisters, and grandmothers - are affected by lupus, a devastating autoimmune disease. We are pleased that Congress is honoring National Women's Health Week along with the ALR, by officially recognizing the importance of education and continued Federal research funding for lupus and other women's health issues," says ALR President Barbara Boyts.

Lupus causes unpredictable symptoms ranging from fatigue and joint pain to severe organ damage, and complications from the disease often prove fatal. The resolution properly recognizes that significant disparities exist in the prevalence of disease among women of different backgrounds. Not only are women in their childbearing years nine times more likely than men to develop lupus, but women of African-American descent are three times more likely to be diagnosed with the disease. Women of Asian, Latin American/Hispanic, Pacific Rim descent are also more likely to be affected. An estimated 1.4 million Americans have lupus.

"This disease disproportionately strikes a typically me
'/>"/>

SOURCE Alliance for Lupus Research
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
2. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
3. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
4. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
5. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
6. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
7. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
8. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
9. Aida Announces New Anti-Cancer Drug Under Development
10. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
11. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 27, 2015  Finesse expands office in Leicester, ... the expansion of its operations in Leicester ... and access for customers is expected shortly afterward. ... adjacent to the current office, the new premises will ... and allow Finesse to bring on more service personnel. ...
(Date:2/26/2015)... , Feb. 26, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ Insulin ... offering of 5,250,000 shares of its common stock at ... The net proceeds to Tandem from this offering are ... and commissions and other estimated offering expenses payable by ...
(Date:2/26/2015)... , Feb. 26, 2015  Today the National ... The psychological and physical side effects of pain medications ... painkillers, such as Vicodin and Oxycontin, are safer options ... overdose on prescription painkillers than on heroin and cocaine ... CEO of NSC. "Yet, these medications are marketed as ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2
(Date:2/27/2015)... (PRWEB) February 27, 2015 Royal River Natural ... reports a new study that found adults who got the ... type 2 diabetes compared to those who got the least ... sugar levels. , The report is part of the March ... which Royal River Natural Foods publishes free each month for ...
(Date:2/27/2015)... February 27, 2015 On February 24 2015, ... Liquid Botox ,” that details the development of RT001, ... working its way through FDA trials. For those afraid of ... is very attractive. Of course, if the drug ultimately gets ... a physician’s office. (see: goo.gl/PQvQwk) , “As the article notes, ...
(Date:2/27/2015)... Winter is here, and with it comes ... to snow and ice can be harmful on a dog’s ... The Puppy Store is ready to help pet owners know ... in the winter time. , Ice melts can lead to ... symptoms. Ingestion of ice melt products may cause depression, loss ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Victorian Hotel ... deals for couples who wanted to spend the auspicious ... opportunity to get a jump on Valentine’s Day with ... stay in one of their luxurious rooms. , ... 13, inviting guests for a mouthwatering 3 course meal ...
(Date:2/27/2015)... February 27, 2015 Mediaplanet today announces ... Health,” a campaign that aims to bring blood health ... care conversation. The stories in this edition go beyond ... of clinical care, hard-hitting advocacy, research and technological strides ... According the American Cancer Society, approximately every 3 ...
Breaking Medicine News(10 mins):Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Is Topical Botox the Next Big Thing? 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2
... a small,molecule pharmaceutical company focused on the discovery ... to the eicosanoid pathway,today announced the appointment of ... Dr. Raizon-Ounis brings 20 years of pharmaceutical experience ... & licensing executive with,Roche Palo Alto. She began ...
... 1, Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) the,global ... Q3 2007 Financial Highlights - Product sales up 41% ... $608.7 million; - Net cash provided by operating activities ... growth now expected to be at least 30% (Q2 guidance: ...
... those with Lou Gehrig,s disease , , THURSDAY, Nov. ... antibiotic minocycline against amyotrophic lateral sclerosis -- Lou ... taking the drug had a significantly accelerated decline ... question plans to try minocycline against other neurodegenerative ...
... Less than a Month, SAN DIEGO, Nov. ... premier certification, education and training organization,recently released results ... for older adults; proving that it works and ... the goal of the study to,encourage older adults ...
... Walk ... Distance (p<0.0006), Conference Call to be ... SILVER SPRING, Md., Nov. 1 United,Therapeutics Corporation (Nasdaq: UTHR ... of their TRIUMPH-1 Phase 3,trial of Viveta, an inhaled formulation of ...
... - Fourth-quarter earnings per share from continuing operations increased ... 15% to 98 cents - ... specified items, increased 15% to ... operations, excluding specified items, to increase 10%-12%, ...
Cached Medicine News:Health News:Amira Pharmaceuticals Appoints First Vice President of Development 2Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 2Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 3Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 4Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 5Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 6Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 7Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 8Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 9Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 10Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 11Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 12Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 13Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 14Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 15Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 16Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 17Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 18Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 19Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 20Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 21Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 22Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 23Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 24Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 25Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 26Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 27Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 28Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 29Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 30Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 31Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 32Health News:Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track 33Health News:Study Shows Antibiotic Harms ALS Patients 2Health News:Exclusive American Council on Exercise (ACE) Research Study Proves Functional Fitness Really Works 2
Chase micro-hemocrit tubes are manufactured from soda lime glass, packed in plastic vials with reclosable snap-lock caps to maintain cleanliness....
Hemato-clad Hematocrit Tubes combine the precision of glass with the safety provided by a Mylar® overwrap. Now you can give your laboratory staff safety with no compromise in accuracy....
... capillary tubes help protect healthcare workers from ... common medical procedures. Each BD plastic-coated micro-hematocrit ... so thin that it does not interfere ... inspection of the sample. The mylar film ...
... In the Innova™ 4100, the ... X-ray system for angiographic imaging, ... piece, non tiled Digital Detector ... reliably provide high resolution imaging ...
Medicine Products: